First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells.

Leukemia

Department of Oncology-Pathology, Immune and Gene Therapy Lab, CancerCenterKarolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.

Published: October 2018

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170396	PMC
http://dx.doi.org/10.1038/s41375-018-0113-1	DOI Listing

Publication Analysis

first-in-class oral

oral small

small molecule

molecule inhibitor

inhibitor tyrosine

tyrosine kinase

kinase ror1

ror1 kan0439834

kan0439834 induced

induced apoptosis

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!